Breaking Finance News

Zacks Investment Research upgraded Entellus Medical Inc (NASDAQ:ENTL) to Hold in a report released today.

Yesterday Entellus Medical Inc (NASDAQ:ENTL) traded -0.11% lower at $16.84. The company’s 50-day moving average is $17.07 and its 200-day moving average is $14.94. The last closing price is up 16.67% from the 200-day moving average, compared to the S&P 500 which has increased 0.05% over the same time period. 78,616 shares of the stock traded hands, down from an average trading volume of 180,594

Zacks Investment Research has upgraded Entellus Medical Inc (NASDAQ:ENTL) to Hold in a report released on Wednesday July 05, 2017.

See Chart Below

Entellus Medical Inc (NASDAQ:ENTL)

Entellus Medical Inc has a 52 week low of $11.47 and a 52 week high of $22.63 The company’s market cap is currently $0.

General Information About Entellus Medical Inc (NASDAQ:ENTL)

Entellus Medical, Inc. is a medical technology company. The Company is focused on delivering patient and physician experiences through products designed for the minimally invasive treatment of chronic and recurrent sinusitis in both adult and pediatric patients. Its three core product lines, XprESS Multi-Sinus Dilation Systems, MiniFESS Surgical Instruments, and FocESS Imaging & Navigation, are designed to enable ear, nose and throat (ENT), physicians to perform a range of procedures in the ENT physician office and to simplify operating room-based treatment. The Company's XprESS Multi-Sinus Dilation family of products consists of its XprESS Pro device, its XprESS LoProfile device and its XprESS Ultra device. The MiniFESS family of surgical instruments includes eight devices designed to enable physicians to perform various surgical procedures. The Fiagon Image Guidance System (IGS) consists of a navigation unit, navigation sensor, software instruments and a patient localizer.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.